The Wall Street Journal:GE Healthcare Announces First U.S. Markets For New Alzheimer's Diagnostic Tool for Detection of Beta Amyloid GE Healthcare Announces First U.S. Markets For New Alzheimer's Diagnostic Tool for Detection of Beta Amyloid